VBI Vaccines Inc (VBIV) Down 2.46% in Premarket Trading

Thursday, September 07, 2023 08:20 AM | InvestorsObserver Analysts

Mentioned in this article

VBI Vaccines Inc (VBIV) is lower by Thursday morning, with the stock decreasing -2.46% in pre-market trading to 1.19. VBIV's short-term technical score of 1 indicates that the stock has traded less bullishly over the last month than 99% of stocks on the market. In the Biotechnology industry, which ranks 131 out of 146 industries, VBIV ranks higher than 1% of stocks. VBI Vaccines Inc has fallen 3.17% over the past month, closing at $1.27 on August 10. During this period of time, the stock fell as low as $1.19 and as high as $1.35. VBIV has an average analyst recommendation of Strong Buy. The company has an average price target of $33.03.

VBIV has an Overall Score of 31. Find out what this means to you and get the rest of the rankings on VBIV!
VBI Vaccines Inc has a Long-Term Technical rank of 1. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 99% of the market scoring higher. In the Biotechnology industry which is number 131 by this metric, VBIV ranks better than 131% of stocks.

Important Dates for Investors in VBIV:

-VBI Vaccines Inc is set to release earnings on 2023-11-12. Over the last 12 months, the company has reported EPS of $-8.58. -We do not have a set dividend date for VBI Vaccines Inc at this time. Click Here To Get The Full Report on VBI Vaccines Inc (VBIV)

Share this article: